NL-OMON33355尚未招募不适用
Pharmacogenomics of anthracycline-induced cardiotoxicity in children with cancer - Pharmacogenomics and anthracycline cardiotoxicity
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diagnosis of childhood cancer and treatment with anthracyclines
- •Decreased heart function and normal heart function
- •Age: at least 18 years old
排除标准
- •Age: below 18 years
研究者
相似试验
已完成
不适用
A cohort study of anthracycline-induced cardiotoxicityAll patients scheduled for anthracycline-containing therapy for various kinds of tumorsJPRN-UMIN000022984niversity of Tsukuba500
已完成
不适用
Early Cardiac Changes During Chemotherapy in Breast CancerChemotherapy induced CardiomyopathyCardiovascular - Other cardiovascular diseasesCancer - BreastBreast CancerACTRN12611000153910Professor Joseph Selvanayagam100
已完成
不适用
Can we detect early chemotherapy related heart damage in patients with lymphoma using advanced echocardiography?CancerISRCTN84544539South Tees NHS Foundation Trust45
进行中（未招募）
不适用
Prevention of anthracycline-induced cardiotoxicity: a multicentre randomizedtrial comparing two therapeutic strategies.EUCTR2012-002248-26-ITISTITUTO EUROPEO DI ONCOLOGIA
已完成
不适用
Primary Prevention of Anthracycline-induced Cardiotoxicity with L-Carnitine in patients with breast Cancer (PPACC): pilot studyBreast CancerCancerISRCTN32332192niversity of Ottawa Heart Institute (Institut de cardiologie de l'Université d'Ottawa) (Canada)144